This page is part of the CH LAB-Order (R4) (v2.0.0-ballot: STU 2 Ballot 1) based on FHIR R4. This is the current published version in its permanent home (it will always be available at this URL). For a full list of available versions, see the Directory of published versions
Active as of 2022-07-01 |
<ChargeItemDefinition xmlns="http://hl7.org/fhir">
<id value="example-lab-billing-vitamind-focus"/>
<meta>
<profile
value="http://hl7.org/fhir/uv/order-catalog/StructureDefinition/LabChargeItemDefinition"/>
</meta>
<language value="de-CH"/>
<text>
<status value="additional"/>
<div xml:lang="de-CH" xmlns="http://www.w3.org/1999/xhtml" lang="de-CH"><p><b>Additional Narrative in French language | Vue narrative en français :</b></p><p>Codage affiné (1139) et conditions d'application du dosage de la vitamine D - Nomenclature des Actes de Biologie Médicale (NABM version 56)</p><p>La prise en charge de cet acte est limitée aux situations suivantes :</p><ul><li>suspicion de rachitisme</li><li>suspicion d’ostéomalacie</li><li>suivi ambulatoire de l’adulte transplanté rénal au-delà de trois mois après transplantation</li><li>avant et après chirurgie bariatrique</li><li>évaluation et prise en charge des personnes âgées sujettes aux chutes répétées</li><li>respect des résumés des caractéristiques du produit (RCP) des médicaments préconisant la réalisation de l’acte 1139</li></ul></div>
</text>
<url
value="http://fhir.ch/ig/ch-lab-order/lab-compendium/ChargeItemDefinition/example-lab-billing-vitamind-focus"/>
<version value="2.0.0-ballot"/>
<title value="Bestimmung von 25-OH-Vitamin D"/>
<status value="active"/>
<date value="2022-07-01"/>
<publisher value="HL7 Switzerland"/>
<contact>
<name value="HL7 Switzerland"/>
<telecom>
<system value="url"/>
<value value="https://www.hl7.ch"/>
</telecom>
</contact>
<contact>
<name value="Marcel Hanselmann"/>
<telecom>
<system value="email"/>
<value value="laborprojektgruppe@gmail.com"/>
<use value="work"/>
</telecom>
</contact>
<description
value="Limitationen. Nur einmal verrechenbar im Falle einer separaten Bestimmung der beiden Formen von 25-HydroxyVitamin-D (25-OH-D3 und 25-OH-D2)"/>
<useContext>
<code>
<system
value="http://terminology.hl7.org/CodeSystem/usage-context-type"/>
<code value="focus"/>
</code>
<valueCodeableConcept>
<coding>
<system value="http://snomed.info/sct"/>
<code value="41345002"/>
<display value="Rickets (disorder)"/>
</coding>
<text value="(Verdacht) Rachitis"/>
</valueCodeableConcept>
</useContext>
<useContext>
<code>
<system
value="http://terminology.hl7.org/CodeSystem/usage-context-type"/>
<code value="focus"/>
</code>
<valueCodeableConcept>
<coding>
<system value="http://snomed.info/sct"/>
<code value="4598005"/>
<display value="Osteomalacia (disorder)"/>
</coding>
<text value="(Verdacht) Osteomalazie"/>
</valueCodeableConcept>
</useContext>
<useContext>
<code>
<system
value="http://terminology.hl7.org/CodeSystem/usage-context-type"/>
<code value="focus"/>
</code>
<valueCodeableConcept>
<coding>
<system value="http://snomed.info/sct"/>
<code value="312894000"/>
<display value="Osteopenia (disorder)"/>
</coding>
<text value="(Verdacht) Osteopenie"/>
</valueCodeableConcept>
</useContext>
<useContext>
<code>
<system
value="http://terminology.hl7.org/CodeSystem/usage-context-type"/>
<code value="focus"/>
</code>
<valueCodeableConcept>
<coding>
<system value="http://snomed.info/sct"/>
<code value="64859006"/>
<display value="Osteoporosis (disorder)"/>
</coding>
<text value="(Verdacht) Osteoporose"/>
</valueCodeableConcept>
</useContext>
<useContext>
<code>
<system
value="http://terminology.hl7.org/CodeSystem/usage-context-type"/>
<code value="focus"/>
</code>
<valueCodeableConcept>
<coding>
<system value="http://snomed.info/sct"/>
<code value="268029009"/>
<display value="Pathological fracture (disorder)"/>
</coding>
<text value="(Verdacht) nicht traumatische Fraktur"/>
</valueCodeableConcept>
</useContext>
<useContext>
<code>
<system
value="http://terminology.hl7.org/CodeSystem/usage-context-type"/>
<code value="focus"/>
</code>
<valueCodeableConcept>
<coding>
<system value="http://snomed.info/sct"/>
<code value="443731004"/>
<display
value="Assessment using falls risk assessment score for the elderly (procedure)"/>
</coding>
<text
value="Beurteilung und Behandlung nach unklarem Sturzereignis bei Patienten ≥ 65 Jahren"/>
</valueCodeableConcept>
</useContext>
<useContext>
<code>
<system
value="http://terminology.hl7.org/CodeSystem/usage-context-type"/>
<code value="focus"/>
</code>
<valueCodeableConcept>
<coding>
<system value="http://snomed.info/sct"/>
<code value="391040000"/>
<display value="At risk of osteoporotic fracture (finding)"/>
</coding>
<text
value="bei anamnestisch erhöhtem Frakturrisiko bei Patienten ≥ 65 Jahre"/>
</valueCodeableConcept>
</useContext>
<useContext>
<code>
<system
value="http://terminology.hl7.org/CodeSystem/usage-context-type"/>
<code value="focus"/>
</code>
<valueCodeableConcept>
<coding>
<system value="http://snomed.info/sct"/>
<code value="90708001"/>
<display value="Kidney disease (disorder)"/>
</coding>
<text value="Nierenerkrankungen, inkl. Urolithiasis"/>
</valueCodeableConcept>
</useContext>
<useContext>
<code>
<system
value="http://terminology.hl7.org/CodeSystem/usage-context-type"/>
<code value="focus"/>
</code>
<valueCodeableConcept>
<coding>
<system value="http://snomed.info/sct"/>
<code value="73132005"/>
<display value="Disorder of parathyroid gland (disorder)"/>
</coding>
<text
value="Störungen des Parathormons, der Kalzämie und/oder der Phosphatämie"/>
</valueCodeableConcept>
</useContext>
<useContext>
<code>
<system
value="http://terminology.hl7.org/CodeSystem/usage-context-type"/>
<code value="focus"/>
</code>
<valueCodeableConcept>
<coding>
<system value="http://snomed.info/sct"/>
<code value="119292006"/>
<display value="Disorder of gastrointestinal tract (disorder)"/>
</coding>
<text value="Gastrointestinale Erkrankungen"/>
</valueCodeableConcept>
</useContext>
<useContext>
<code>
<system
value="http://terminology.hl7.org/CodeSystem/usage-context-type"/>
<code value="focus"/>
</code>
<valueCodeableConcept>
<coding>
<system value="http://snomed.info/sct"/>
<code value="32230006"/>
<display value="Malabsorption syndrome (disorder)"/>
</coding>
<text value="Malabsorptionssyndrome"/>
</valueCodeableConcept>
</useContext>
<useContext>
<code>
<system
value="http://terminology.hl7.org/CodeSystem/usage-context-type"/>
<code value="focus"/>
</code>
<valueCodeableConcept>
<coding>
<system value="http://snomed.info/sct"/>
<code value="235856003"/>
<display value="Disorder of liver (disorder)"/>
</coding>
<text value="Lebererkrankungen"/>
</valueCodeableConcept>
</useContext>
<useContext>
<code>
<system
value="http://terminology.hl7.org/CodeSystem/usage-context-type"/>
<code value="focus"/>
</code>
<valueCodeableConcept>
<coding>
<system value="http://snomed.info/sct"/>
<code value="182817000"/>
<display value="Drug prescription (situation)"/>
</coding>
<text
value="Patienten, die Medikamente, die den Vit. D Stoffwechsel beeinflussen, einnehmen"/>
</valueCodeableConcept>
</useContext>
<jurisdiction>
<coding>
<system value="urn:iso:std:iso:3166"/>
<code value="CH"/>
</coding>
</jurisdiction>
<copyright value="CC0-1.0"/>
<code>
<coding>
<system value="https://medcodesearch.ch/de/AL/laboratory_analyses"/>
<code value="1006.00"/>
<display value="Vitamin D"/>
</coding>
</code>
</ChargeItemDefinition>
IG © 2021+ HL7 Switzerland. Package ch.fhir.ig.ch-lab-order#2.0.0-ballot based on FHIR 4.0.1. Generated 2023-06-29
Links: Table of Contents |
QA Report
| Propose a change